Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells
- PMID: 82582
Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells
Abstract
Suppressor T cells arising during the development of certain murine methylcholanthrene-induced fibrosarcomas have previously been shown capable of limiting only those effector responses generated against the homologous tumor. Thus, S1509a-induced suppressor T cells inhibit immune reactivity only to the S1509a tumor in S1509a immune mice and have no effect on the rejection of SAI tumors in SAI-immune animals. In contrast to this is the cross-reactivity of effector cells in this system, whereby animals rendered immune to either the S1509a or SAI sarcoma are equally capable of rejecting a challenge of the opposite tumor. The specificity of suppression has been further defined in the present study, which demonstrates that S1509a-induced suppressor cells can inhibit responsiveness only to the S1509a sarcoma, even in the simultaneous presence of both the S1509a and SAI tumors. Furthermore, the suppressor factor that is obtainable from suppressor T cells demonstrates a similar precise specificity in its ability to limit selectively reactivity only against the inducing tumor, regardless of the simultaneous expression of antigens on other tumors recognized by cross-reactive effector cells. These results suggest that the antigenic determinants recognized by effector and suppressor T cells are different, and may provide a model for further dissection of suppressor cell function in vivo.
Similar articles
-
Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.J Immunol. 1978 Dec;121(6):2144-7. J Immunol. 1978. PMID: 82578
-
Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses.J Immunol. 1984 Aug;133(2):1064-9. J Immunol. 1984. PMID: 6234349
-
Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.J Immunol. 1983 Feb;130(2):997-1002. J Immunol. 1983. PMID: 6184410
-
Differential antigen presentation in tumor immunity.Fed Proc. 1984 Jun;43(9):2460-4. Fed Proc. 1984. PMID: 6327399 Review.
-
Modulation of immune responses by suppressor T cells.Fed Proc. 1978 Aug;37(10):2361-64. Fed Proc. 1978. PMID: 79503 Review.
Cited by
-
Kinetics of the reactivity of subpopulations of spleen cells of mice bearing virus-induced mammary tumors to syngeneic antigenic extracts in vitro. Supportive and suppressive effects of macrophages.Cancer Immunol Immunother. 1982;13(2):98-104. doi: 10.1007/BF00205308. Cancer Immunol Immunother. 1982. PMID: 6297714 Free PMC article.
-
Patterns of T cell subset alterations in myelo- and lymphoproliferative disorders.Blut. 1984 May;48(5):321-5. doi: 10.1007/BF00320403. Blut. 1984. PMID: 6609731
-
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: T-lymphocyte-mediated immunosuppression.Infect Immun. 1985 Oct;50(1):169-74. doi: 10.1128/iai.50.1.169-174.1985. Infect Immun. 1985. PMID: 2931377 Free PMC article.
-
Suppressor mechanisms in tumor immunity.Experientia. 1983 Mar 15;39(3):235-42. doi: 10.1007/BF01955286. Experientia. 1983. PMID: 6186519 Review.
-
Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies.J Exp Med. 1982 Aug 1;156(2):480-91. doi: 10.1084/jem.156.2.480. J Exp Med. 1982. PMID: 6212625 Free PMC article.